InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: fuente post# 27492

Monday, 12/10/2012 11:43:28 AM

Monday, December 10, 2012 11:43:28 AM

Post# of 330589
Hey Fuente
I believe you are correct but I also think the place we are at as investors is potentially a very good one.
There are numerous companies and devices in limbo at the FDA for re-classification, or not.
Obviously the FDA is addressing a number of issues at great cost and passage of time. They would not be doing so without a professional desire to receive submissions, listen to input and get it right
The device space BIEL is in was clearly muddled before, so clarity will be a good thing for that space, and hopefully for BIEL.
Having said all that, is it not a good thing to have BIEL alive and in the running for re-classification coming out of the April meeting?
I think it bodes well for the company and the share price.
Bottom line is the products work very well, zero side-effects and they will help people manage pain, drug free. No downside as I see it.